No matches

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ChinaChange country/region

Dermatology

Nicholas Mollanazar

MBA, MD

Assistant Professor of Clinical Dermatology; Director of Access, Dermatology; Co-Chair, Electronic Medical Record Governance | University of Pennsylvania Perelman School of Medicine, Philadelphia, United States

Biography

Nicholas K. Mollanazar, MD, is assistant professor of clinical dermatology at the University of Pennsylvania Perelman School of Medicine in Philadelphia, PA, where he is also director of patient access in the Department of Dermatology. He earned his doctor of medicine degree from the Temple University School of Medicine in Philadelphia and completed a residency in internal medicine at Pennsylvania Hospital, followed by a dermatology residency at Temple University Hospital, where he served as chief resident.

As a clinician, Dr Mollanazar treats patients for a wide range of skin conditions, particularly those involving chronic pruritus. His research interests, however, have become increasingly focused on the rare disease prurigo nodularis.

Professional memberships include the Medical Dermatology Society and the American Academy of Dermatology.